Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,077 | 76 | 92.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $62.87 | 1 | 5.4% |
| Education | $30.06 | 2 | 2.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $147.42 | 10 | $0 (2021) |
| AbbVie Inc. | $117.64 | 13 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $104.28 | 8 | $0 (2021) |
| Dexcom, Inc. | $102.38 | 5 | $0 (2023) |
| PFIZER INC. | $95.07 | 7 | $0 (2020) |
| Novo Nordisk Inc | $93.70 | 7 | $0 (2021) |
| Indivior Inc. | $62.87 | 1 | $0 (2017) |
| Amarin Pharma Inc. | $56.70 | 4 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $54.25 | 4 | $0 (2021) |
| Medtronic MiniMed, Inc. | $49.08 | 2 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $68.45 | 4 | Dexcom, Inc. ($38.42) |
| 2022 | $30.75 | 2 | Dexcom, Inc. ($18.12) |
| 2021 | $452.66 | 35 | AbbVie Inc. ($117.64) |
| 2020 | $259.70 | 16 | Amgen Inc. ($46.37) |
| 2019 | $222.20 | 17 | Amgen Inc. ($53.94) |
| 2018 | $73.27 | 4 | PFIZER INC. ($44.74) |
| 2017 | $62.87 | 1 | Indivior Inc. ($62.87) |
All Payment Transactions
79 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/23/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: Endocrinology | ||||||
| 03/21/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $21.53 | General |
| Category: Endocrinology | ||||||
| 03/14/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $12.78 | General |
| Category: Oncology | ||||||
| 02/17/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: Diabetes | ||||||
| 07/18/2022 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), BEXSERO | Food and Beverage | In-kind items and services | $12.63 | General |
| Category: VACCINES | ||||||
| 03/17/2022 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: Endocrinology | ||||||
| 11/03/2021 | DEXCOM, INC. | DEXCOM G6 TRANSMITTER (Device) | Food and Beverage | In-kind items and services | $23.05 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/22/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: NEUROSCIENCE | ||||||
| 09/14/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/31/2021 | DEXCOM, INC. | DEXCOM G6 TRANSMITTER (Device) | Food and Beverage | In-kind items and services | $22.79 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/24/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $11.68 | General |
| Category: Diabetes | ||||||
| 08/19/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.63 | General |
| Category: NEUROSCIENCE | ||||||
| 08/12/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: DIABETES | ||||||
| 08/09/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: Diabetes | ||||||
| 08/03/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $11.76 | General |
| Category: Respiratory | ||||||
| 07/29/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: Cardiovascular | ||||||
| 07/28/2021 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: Bone Health | ||||||
| 07/20/2021 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: Inflammation | ||||||
| 07/07/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.44 | General |
| Category: Cardiovascular | ||||||
| 06/29/2021 | Amgen Inc. | Aimovig (Biological), Otezla, Repatha | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: Neuroscience | ||||||
| 06/28/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: NEUROSCIENCE | ||||||
| 06/24/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), TRIJARDY XR | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: DIABETES | ||||||
| 06/14/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.22 | General |
| Category: NEUROSCIENCE | ||||||
| 06/08/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $12.23 | General |
| Category: Diabetes | ||||||
| 05/18/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 25 | 27 | $759.00 | $571.22 |
| 2022 | 2 | 45 | 50 | $1,188 | $702.80 |
| 2021 | 2 | 25 | 25 | $818.00 | $174.22 |
| 2020 | 3 | 66 | 72 | $2,446 | $629.64 |
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 12 | 12 | $684.00 | $542.62 | 79.3% |
| 81003 | Automated urinalysis test | Office | 2023 | 13 | 15 | $75.00 | $28.60 | 38.1% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2022 | 20 | 21 | $840.00 | $638.58 | 76.0% |
| 81003 | Automated urinalysis test | Office | 2022 | 25 | 29 | $348.00 | $64.22 | 18.5% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 14 | 14 | $532.00 | $135.94 | 25.6% |
| 81002 | Urinalysis, manual test | Office | 2021 | 11 | 11 | $286.00 | $38.28 | 13.4% |
| 71046 | X-ray of chest, 2 views | Office | 2020 | 26 | 29 | $1,208 | $314.01 | 26.0% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 25 | 27 | $972.00 | $260.65 | 26.8% |
| 81002 | Urinalysis, manual test | Office | 2020 | 15 | 16 | $266.00 | $54.98 | 20.7% |
About Dr. Cathy Cody, M.D
Dr. Cathy Cody, M.D is a Family Medicine healthcare provider based in Centralia, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/25/2010. The National Provider Identifier (NPI) number assigned to this provider is 1225349111.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Cathy Cody, M.D has received a total of $1,170 in payments from pharmaceutical and medical device companies, with $68.45 received in 2023. These payments were reported across 79 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($1,077).
As a Medicare-enrolled provider, Cody has provided services to 161 Medicare beneficiaries, totaling 174 services with total Medicare billing of $2,078. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Centralia, MO
- Active Since 06/25/2010
- Last Updated 03/15/2016
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1225349111
Products in Payments
- VRAYLAR (Drug) $93.24
- Aimovig (Biological) $89.33
- Ozempic (Drug) $77.84
- FARXIGA (Drug) $77.73
- UBRELVY (Drug) $66.26
- SUBOXONE SUBLINGUAL FILM (Drug) $62.87
- Vascepa (Drug) $56.70
- Dexcom G6 Transmitter (Medical Supply) $56.54
- DEXCOM G6 TRANSMITTER (Device) $45.84
- JARDIANCE (Drug) $42.54
- EVENITY (Biological) $42.04
- MYRBETRIQ (Drug) $41.96
- CHANTIX (Drug) $41.54
- ENTRESTO (Drug) $40.69
- Prolastin-C Liquid (Biological) $30.78
- Minimed 670G System (Device) $28.53
- PREVNAR - 13 (Biological) $25.42
- BEXSERO (Biological) $23.67
- LONHALA MAGNAIR (Drug) $21.39
- Minimed 630G (Device) $20.55
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Centralia
Niranjan Shrestha, M.d., Faafp, M.D., FAAFP
Family Medicine — Payments: $24,048
Rebecca Kelley, M.d, M.D
Family Medicine — Payments: $2,022
Dr. Usha Sadanala, Md, MD
Family Medicine — Payments: $1,793
Dr. Affan Rabbani, M.d, M.D
Family Medicine — Payments: $1,135
Dr. Balavittal Varanasi, M.d, M.D
Family Medicine — Payments: $888.61
Blake Busey, D.o, D.O
Family Medicine — Payments: $263.59